4//SEC Filing
Maslan Andrew Scott 4
Accession 0001144204-10-019757
CIK 0001091596other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 3:13 PM ET
Size
8.5 KB
Accession
0001144204-10-019757
Insider Transaction Report
Form 4
Maslan Andrew Scott
Chief Financial Officer
Transactions
- Purchase
10% Series D Convertible Stock
2010-04-09+0→ 367,321 totalExercise: $0.56→ Common Stock (17,921 underlying) - Purchase
Common Stock Warrants
2010-04-09+0→ 376,282 totalExercise: $0.54Exp: 2015-04-09→ Common Stock (8,961 underlying)
Footnotes (1)
- [F1]Represents the number of shares of common stock of the Company issuable upon exercise of the shares of the 10% Series D Convertible Preferred Stock at the face value of $1,000 per share (the "Preferred Stock") and warrants to purchase shares of common stock (the "Warrants", collectively, the "Securities") purchased by the Reporting Person in connection with the April 2010 private placement of the Securities by the Company. The Preferred Stock may be converted, at the holder's option, into shares of the Common Stock at the set conversion price, and the Warrants are exercisable on the issuance date and will expire on April 9, 2015. Conversions of the Preferred Stock and exercise of the Warrants are subject to numeric limitations and shareholder approval as described in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission relating to the private placement of the subject Securities.
Documents
Issuer
CYTOMEDIX INC
CIK 0001091596
Entity typeother
Related Parties
1- filerCIK 0001332669
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 3:13 PM ET
- Size
- 8.5 KB